万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生2>>遗传学

MOLECULAR GENETICS & GENOMIC MEDICINE《分子遗传学与基因组医学》 (官网投稿)

简介
  • 期刊简称MOL GENET GENOM MED
  • 参考译名《分子遗传学与基因组医学》
  • 核心类别 SCIE(2023版), 目次收录(知网),外文期刊,
  • IF影响因子
  • 自引率3.10%
  • 主要研究方向医学-GENETICS & HEREDITY遗传学

主要研究方向:

等待设置主要研究方向
医学-GENETICS & HEREDITY遗传学

MOLECULAR GENETICS & GENOMIC MEDICINE《分子遗传学与基因组医学》(月刊). Molecular Genetics & Genomic Medicine is a peer-reviewed journal for rapid dissemina...[显示全部]
征稿信息

万维提示:

1、投稿方式:官网投稿。

2、期刊网址:

https://onlinelibrary.wiley.com/journal/23249269

3、投稿网址:

https://mc.manuscriptcentral.com/MGGM

4、官网邮箱:%20mggm@wiley.com(编辑部)

更多邮箱请查看官网信息。

5、期刊刊期:月刊,一年出版12期。

          20220111日星期二

                     

 

投稿须知【官网信息】

                      

MOLECULAR GENETICS & GENOMIC MEDICINE

1. SUBMISSION

Authors should kindly note that submission implies that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium. 

Once the submission materials have been prepared in accordance with the Author Guidelines, manuscripts should be submitted via the journals ScholarOne site: https://mc.manuscriptcentral.com/MGGM. For more details on how to use ScholarOne, visit www.wileyauthors.com/scholarone. Note, this journal uses iThenticates CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts.

The submission system will prompt the author to use an ORCiD ID (a unique author identifier) to help distinguish their work from that of other researchers. Click here to find out more.

Data Protection

By submitting a manuscript to or reviewing for this publication, your name, email address, and affiliation, and other contact details the publication might require, will be used for the regular operations of the publication, including, when necessary, sharing with the publisher (Wiley) and partners for production and publication. The publication and the publisher recognize the importance of protecting the personal information collected from users in the operation of these services, and have practices in place to ensure that steps are taken to maintain the security, integrity, and privacy of the personal data collected and processed. You can learn more at authorservices.wiley.com/statements/data-protection-policy.

For help with submissions, please contact the Editorial Office: mggm@wiley.com. When necessary, the Editorial Office staff may refer questions to the Editor-in-Chief.

Return to Guideline Sections

2. AIMS AND SCOPE

Molecular Genetics & Genomic Medicine is a peer-reviewed journal for rapid dissemination of quality research related to the dynamically developing areas of human, molecular and medical genetics. The journal publishes original research articles covering findings in phenotypic, molecular, biological, and genomic aspects of genomic variation, inherited disorders and birth defects. The broad publishing spectrum of Molecular Genetics & Genomic Medicine includes rare and common disorders from diagnosis to treatment. Examples of appropriate articles include reports of novel disease genes, functional studies of genetic variants, in-depth genotype-phenotype studies, genomic analysis of inherited disorders and cancer, molecular diagnostic methods, medical bioinformatics, ethical, legal, and social implications (ELSI), epidemiological studies, and approaches to clinical diagnosis. Molecular Genetics & Genomic Medicine provides a scientific home for next generation sequencing studies of rare and common disorders, which will make research in this fascinating area easily and rapidly accessible to the scientific community. This will serve as the basis for translating next generation sequencing studies into individualized diagnostics and therapeutics, for day-to-day medical care.

Molecular Genetics & Genomic Medicine publishes original research articles, reviews, and research methods papers, along with invited editorials and commentaries. Original research papers must report well-conducted research with conclusions supported by the data presented.

Molecular Genetics & Genomic Medicine is a Wiley Open Access journal, one of a series of peer reviewed titles publishing quality research with speed and efficiency. Authors of accepted papers pay an Article Publication Charge and their papers are published under a Creative Commons license. With Creative Commons licenses, the author retains copyright and the public is allowed to reuse the content. The author grants Wiley a license to publish the article and identify as the original publisher. To find out which Created Commons Licenses are available for the journal, click here. For further information visit the Wiley Open Access website.

Return to Guideline Sections

3. MANUSCRIPT CATEGORIES AND REQUIREMENTS

MANUSCRIPT TYPES

Original Research Articles

Clinical Reports

Reviews

Methods

Invited Commentaries

GENERAL INSTRUCTIONS

 

Manuscripts must be submitted in grammatically correct English. Manuscripts that do not meet this standard cannot be reviewed. Authors for whom English is a second language may wish to consult an English-speaking colleague or consider having their manuscript professionally edited before submission to improve the English. A list of independent suppliers of editing services can be found at http://authorservices.wiley.com/bauthor/english_language.asp. All services are paid for and arranged by the author, and use of one of these services does not guarantee acceptance or preference for publication. A manuscript is considered for review and possible publication on the condition that it is submitted solely to Molecular Genetics and Genomic Medicine, and that the manuscript or a substantial portion of it is not under consideration elsewhere.

Novel nucleotide sequence data including genetic mutations must be submitted to a public database prior to publication. See the Sequence Data section, below.

MANUSCRIPT TERMINOLOGY

Manuscript wording and terminology should reflect the Journals preferred criteria in describing and referring to human beings. Individuals described within a manuscript should be regarded with sensitivity. They should be referred to as patients rather than cases or as having a condition rather than being simply labeled by a specific terminology. Consider and avoid any stigmatizing terms, such as simian. If it is necessary to identify an individual, use a numerical designation (e.g. Patient 1) rather than using any other identifying notations such as initials. Phenotypic descriptors should be standardized as much as possible and follow these guidelines from the Elements of Morphology project: http://onlinelibrary.wiley.com/doi/10.1002/ajmg.a.v149a:1/issuetoc

……

更多详情:

https://onlinelibrary.wiley.com/page/journal/23249269/homepage/forauthors.html


  • 万维QQ投稿交流群    招募志愿者

    版权所有 Copyright@2009-2015豫ICP证合字09037080号

     纯自助论文投稿平台    E-mail:eshukan@163.com


投稿问答最小化  关闭